Epilepsy and pregnancy: identifying risks

被引:4
作者
Craig, John J. [1 ]
Scott, Shona [2 ]
Leach, John Paul [3 ]
机构
[1] Belfast Hlth & Social Care Trust, Neurol, Belfast, Antrim, North Ireland
[2] Univ Edinburgh, Dept Clin Neurosci, Div Med & Radiol Sci, Edinburgh, Midlothian, Scotland
[3] Univ Glasgow, Sch Med, Glasgow G12 8QQ, Lanark, Scotland
关键词
epilepsy; obstetrics; anticonvulsants; sudden death; ANTIEPILEPTIC DRUG EXPOSURE; CONGENITAL-MALFORMATIONS; PLASMA-CONCENTRATIONS; COGNITIVE OUTCOMES; SEIZURE FREQUENCY; EURAP EPILEPSY; UK EPILEPSY; WOMEN; AGE; LAMOTRIGINE;
D O I
10.1136/practneurol-2019-002304
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pregnancy is a time of physical, physiological and psychological challenge. For women with epilepsy, as well as its potential for joy and fulfilment, pregnancy may bring additional risks and difficulties. Clinicians must anticipate and prevent these complications, ensuring that pregnancy, delivery and motherhood proceed without obstetric or medical complications, using available evidence to balance individual risks of undertreatment and overtreatment. Here we review epilepsy management in pregnancy, identifying some of the known effects of epilepsy and its treatment on gestation, fetal malformation, delivery, and neurocognitive and behavioural development. We outline strategies to reduce obstetric and fetal complications in women with epilepsy, while recognising the sometimes competing need to maintain or improve seizure control. We reinforce the importance of identifying those at highest risk, who may require additional measures or safeguards.
引用
收藏
页码:98 / +
页数:11
相关论文
共 70 条
  • [31] Host factors affecting antiepileptic drug delivery-Pharmacokinetic variability
    Landmark, Cecilie Johannessen
    Johannessen, Svein I.
    Tomson, Torbjorn
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 (10) : 896 - 910
  • [32] Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group
    Leach, J. P.
    Smith, P. E.
    Craig, J.
    Bagary, M.
    Cavanagh, D.
    Duncan, S.
    Kelso, A. R. C.
    Marson, A. G.
    McCorry, D.
    Nashef, L.
    Nelson-Piercy, C.
    Northridge, R.
    Sieradzan, K.
    Thangaratinam, S.
    Walker, M.
    Winterbottom, J.
    Reuber, M.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 50 : 67 - 72
  • [33] Adherence to medication for chronic disorders during pregnancy: results from a multinational study
    Lupattelli, Angela
    Spigset, Olav
    Nordeng, Hedvig
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2014, 36 (01) : 145 - 153
  • [34] Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States
    MacDonald, Sarah C.
    Bateman, Brian T.
    McElrath, Thomas F.
    Hernandez-Diaz, Sonia
    [J]. JAMA NEUROLOGY, 2015, 72 (09) : 981 - 988
  • [35] Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney, E.
    Campbell, J.
    Craig, J.
    Russell, A.
    Smithson, W.
    Parsons, L.
    Robertson, I.
    Irwin, B.
    Morrison, P.
    Liggan, B.
    Delanty, N.
    Hunt, S.
    Morrow, J.
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2012, 21 (03): : 215 - 218
  • [36] Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts
    Meador, Kimford
    Reynolds, Matthew W.
    Crean, Sheila
    Fahrbach, Kyle
    Probst, Corey
    [J]. EPILEPSY RESEARCH, 2008, 81 (01) : 1 - 13
  • [37] Breastfeeding in Children of Women Taking Antiepileptic Drugs Cognitive Outcomes at Age 6 Years
    Meador, Kimford J.
    Baker, Gus A.
    Browning, Nancy
    Cohen, Morris J.
    Bromley, Rebecca L.
    Clayton-Smith, Jill
    Kalayjian, Laura A.
    Kanner, Andres
    Liporace, Joyce D.
    Pennell, Page B.
    Privitera, Michael
    Loring, David W.
    [J]. JAMA PEDIATRICS, 2014, 168 (08) : 729 - 736
  • [38] Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study
    Meador, Kimford J.
    Baker, Gus A.
    Browning, Nancy
    Cohen, Morris J.
    Bromley, Rebecca L.
    Clayton-Smith, Jill
    Kalayjian, Laura A.
    Kanner, Andres
    Liporace, Joyce D.
    Pennell, Page B.
    Privitera, Michael
    Loring, David W.
    [J]. LANCET NEUROLOGY, 2013, 12 (03) : 244 - 252
  • [39] Medications and Healthcare products Regulatory Agency, 2021, ANTIEPILEPTIC DRUGS
  • [40] Medicines and Healthcare products Regulatory Agency, VALPR PREGN PROGR AC